A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
Clinical trial NCT00000625 · COMPLETED
Trial details
- NCT number
- NCT00000625
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 2100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.